Wens FSPL, Zonca F, van Tinteren H, Timmermann B, Laprie A, Boterberg T, Gaze M, Lim P, Jazmati D, Dieckmann K, Vennarini S, Melchior P, Weber B, Albiac MR, Szulc A, Grigorenko V, Magelssen H, van Beek K, Graf N, Papadakis V, Neggers SJCMM, van den Heuvel-Eibrink MM, Janssens GO, Polak R (2025)
Late toxicity after upper abdominal radiotherapy in pediatric Wilms tumor and neuroblastoma survivors. A systematic review on behalf of SIOPEN and SIOP-RTSG
Radiother Oncol, 209, 110961 (in press)
DOI 10.1016/j.radonc.2025.110961, PubMed 40441488

Dávila Fajardo R, Magelssen H, Cameron AL, Boterberg T, Mandeville HC (2025)
Current and Future Developments in Radiation Oncology Approach for Rhabdomyosarcoma
Cancers (Basel), 17 (10)
DOI 10.3390/cancers17101618, PubMed 40427117

Heinrich MC, Blay JY, Gelderblom H, George S, Schöffski P, von Mehren M, Zalcberg JR, Jones RL, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Boye K, Goldstein D, Sánchez C, Siontis BL, Cox P, Davis E, Sherman ML, Ruiz-Soto R, Bauer S (2025)
Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE
J Clin Oncol, JCO2402818 (in press)
DOI 10.1200/JCO-24-02818, PubMed 40408605